Nanogen has just increased its capital from 715 billion dong to more than 806 billion dong, the founding shareholder has only 2 individuals, Mr. and Mrs. Ho Nhan. Ms. Nguyen Thi Hong Van is currently the General Director and legal representative.
Author of Vietnamese vaccine Nanocovax
On March 18, the Government Office issued a document conveying the opinions of Deputy Prime Minister Vu Duc Dam on the results of considering the issuance of a registration certificate for the circulation of the Nanocovax vaccine.
Considering the report of the Ministry of Health on the results of reviewing the application for a certificate of circulation of the Nanocovax vaccine against Covid-19 registered and manufactured by the Nanogen Pharmaceutical Biotechnology Joint Stock Company, the Government leaders requested the Ministry of Health to urgently implement the Prime Minister’s direction according to Document No. 1027 dated February 17, 2022 of the Prime Minister. Government Office and other relevant documents; continue to guide and support enterprises in all cases as prescribed by law.
The Covid-19 vaccine Nanocovax has been developed by Nanogen Pharmaceutical Biotechnology Joint Stock Company since May 2020, based on recombinant protein technology.
Before the phase 3 trial, this vaccine has undergone 2 phases of clinical trials: phase 1 starting from December 18, 2020, phase 2 from February 26, 2021 and phase 3 officially from 11/6/2021.
Nanogen Pharmaceutical Biotechnology Joint Stock Company was established in 1997 with the main field of production of biopharmaceutical materials and finished products for injections from recombinant DNA/protein technology.
On the company’s website, Nanogen states that its ambition is “to transform itself into a world-class pharmaceutical biotechnology company”.
“We are proud to be a researcher, developer and successful application of the leading biotechnology advances in the Asia Pacific region in the production of pharmaceutical materials and finished products for special injections. from recombinant DNA/protein technology”, business said.
Nanogen is developing specialized product lines for hepatitis B, hepatitis C, anemia, cancer… In addition, the company also said that it is constantly researching, inventing, and conducting clinical trials of product lines. Antibody products used in cancer immunotherapy, vaccines and therapies to treat Covid-19.
Nanogen’s facilities have 4 factories, 1 research and development center in Vietnam with a total area of 73,000 m2. With a capacity of over 50 million products/year, Nanogen has distributed products to 15 countries in Asia, Europe, Africa and America.
Mr. Ho Nhan – “boss” Nanogen.
This enterprise is chaired by Mr. Ho Nhan (SN 1966). According to the information shared above ForbesMr. Ho Nhan grew up in New York, earned a doctorate in biotechnology from the University of Arizona and cherished the dream of starting his own biotech company.
He has experience in the financial sector, through mergers and acquisitions in the fields of pharmacy, hospital and medical equipment in the US and Hong Kong.
During the period 4/2013 – 9/2017, Mr. Ho Nhan was a member of the Board of Directors of VinaSecurities Securities Company. In addition, this businessman also holds 316,087 shares in One World Service Joint Stock Company (ONW) and is a major shareholder of ONW with an ownership rate of up to 15.8% (as of November 2016). .
The role of Mr. and Mrs. Ho Nhan in Nanogen
According to the latest update on the National Enterprise Portal, on December 29, 2021, Nanogen’s legal representative changed from Mr. Ho Nhan – Chairman of the Board of Directors to Ms. Nguyen Thi Hong Van. Mr. Nhan’s wife.
At the same time, the title of General Director, which was concurrently held by Mr. Ho Nhan, was also transferred to Ms. Van. Thus, Ms. Van is currently the General Director and legal representative of Nanogen.
Nguyen Thi Hong Van has assumed the position of General Director of Nanogen from the end of 2021.
In the first stage, Mr. Ho Nhan owns 70% of the shares of this company, his wife, Ms. Nguyen Thi Hong Van holds 25% of the shares; The remaining 5% belongs to Mr. Ho Vu Thanh. However, after that, this ratio changed significantly with the participation of foreign shareholders.
In the capital increase in May 2019, the company’s charter capital increased from VND 698.75 billion to VND 715 billion through a share offering to foreign shareholders. Accordingly, the capital contribution ratio of foreign investors has increased from 16.28% (equivalent to 113.75 billion VND) to 25.68% (equivalent to 183.63 billion VND).
By March 2021, Nanogen continued to increase its capital from VND 715 billion to VND 806.25 billion. The shareholder structure of the enterprise continues to fluctuate.
At this time, the list of founding shareholders only has 2 individuals, Mr. and Mrs. Ho Nhan. In which, Mr. Nhan owns approximately 59.6% of shares with the value of contributed capital of VND 480.52 billion. Ms. Nguyen Thi Hong Van contributed 117.8 billion VND and accounted for 14.61% of charter capital.
Ho Nhan and his wife are founding members of Nanogen.
Foreign shareholders have 9 organizations and individuals, of which, KIS Vietnam Securities Joint Stock Company holds 0.2% of Nanogen’s charter capital (contributing VND 1.63 billion with a holding amount of 162,550 shares. ).
In the 2020 semi-annual report of KIS Vietnam, the company assessed the value of the above investment as approximately VND 11.6 billion, equivalent to the valuation that KIS Vietnam for Nanogen is up to VND 5,099 billion.
At the above time, KIS noted that it is not possible to determine the fair value of Nanogen at the moment because the company has not been listed on the stock market. If the Covid-19 vaccine is successfully developed, the possibility of pricing with Nanogen will increase.
The current CEO of Nanogen – Ms. Nguyen Thi Hong Van – is known as the eldest daughter of the famous Son Kim family. Ms. Van is the daughter of Mrs. Nguyen Thi Son – the owner of the largest garment business in Vietnam in the early 1990s.
The story of SonKim Group originates from the mid-1950s under the establishment of Dai Thanh – the leading famous textile corporation in Vietnam, which has been passed down through 3 generations.
With a solid foundation built from previous generations, the 3rd generation of the Nguyen family established SonKim Investment and Development Company in 1993. The scale of the company spans from the real estate sector. production, communication to retail with the exploitation and management of famous fashion brands.
According to Dan Tri
at Blogtuan.info – Source: 2sao.vn – Read the original article here